Douglas Campbell, MBA

Douglas Campbell joined Cygnal Therapeutics as Vice President, Finance in August 2021. Throughout his more than 13-year career in the life sciences, Doug has helped to grow and develop a number of young companies in different strategy and finance capacities. He came to Cygnal most recently from Xilio Therapeutics, where he served as Head of Financial Planning and Analysis. Doug has also held roles at Eloxx Pharmaceuticals, Sunovion Pharmaceuticals, Merrimack Pharmaceuticals, and Momenta Pharmaceuticals. From 2008 to 2014, he served in several corporate finance roles of growing responsibility at Biogen.

Prior to his career in the life sciences, Doug served in the U.S. Navy as a Lieutenant Commander from 1995-1999 and 2005-2006. He received his BA in civil engineering from Worcester Polytechnic Institute and his MBA from the University of Chicago Booth School of Business.

Douglas Campbell, MBA headshot

Cygnal is a best-in-class team of biomedical experts and leaders collaborating to revolutionize how the world treats diseases.